Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Q: Paragraph: Made by Bayer AG and Onyx Pharmaceuticals Inc, Nexavar is  approved in the United States for kidney and liver cancer. Eight out of the first nine patients who took the drug saw  improvements in their ability to exercise, and six out of nine  had significant improvement in their right ventricular ejection  fraction, which measures the heart’s ability to pump blood to  the lungs. Four patients had decreased pressure in their pulmonary  artery, which supplies blood to the lungs. “What patients are telling us is they are able to do more  in their daily lives,” said Dr. Mardi Gomberg-Maitland of the  University of Chicago, who presented her findings at a meeting  of the American Thoracic Society in Toronto. The original  research on the drug was done at the University. She said the surprising thing is that the drug worked so  quickly. Patients saw benefits in only four months. The study is the first human trial to examine the  sorafenib, or Nexavar, in pulmonary hypertension, a disease in  which blood vessels feeding the lungs narrow, forcing the heart  to work harder. Like cancer, pulmonary hypertension is a disease marked by  abnormal cell growth, which narrows the arteries feeding the  lungs, reducing blood flow and taxing the heart. Sorafenib  appears to interfere with this process. The trial enrolled patients with stable disease who  continued to take their primary medications, which included a  continuous infusion of a drug called prostacyclin and Pfizer  Inc’s Viagra or sildenafil. Both relax blood vessels that feed  the lungs. Gomberg-Maitland said this therapy typically slows  progression of the disease, but does not reverse it. They added sorafenib for 16 weeks, but at a lower dose than  cancer patients use. Most patients in the trial increased their exercise  capacity, as measured by time on a treadmill or a six-minute  walk test. They saw an average 8 percent improvement in their  right ventricular ejection fraction, a measure of the heart’s  pumping power. Side effects included mild hair loss and skin reactions. The study was designed to last only 16 weeks, but all of  the patients continue to take the drug, some now for more than  a year. “What is exciting about this is all of the patients feel  better and nobody wants to come off the medication,”  Gomberg-Maitland said in a telephone interview. The study was intended to test the safety and dosing of the  drug. It was funded by The Doris Duke Foundation and the  University of Chicago. The researchers now plan to study the drug in 40 to 60  patients at different research centers. Claim: Nexavar helped in pulmonary hypertension study.

A: The cancer drug Nexavar is showed  promise in a small study of people with pulmonary hypertension,  a debilitating condition marked by high blood pressure in the  arteries that supply the lungs, U.S. researchers said on  Monday.
****
Q: Paragraph: Three of the other five patients are in either a serious or a critical condition in hospital, while the remaining two have mild symptoms, the United Nations health agency said in a disease outbreak update. H7N9 bird flu emerged last year in China and has infected around 150 people so far there and in Taiwan and Hong Kong, killing at least 46 of them. The latest death was a 38-year-old man from China’s Fujian Province who became ill with H7N9 on January 3, was admitted to hospital on January 8 but died 2 days later. He had underlying illnesses, including tuberculosis and pneumoconiosis. China’s state news agency Xinhua reported another death from H7N9 in the southwestern Guizhou province on Monday, but this has yet to be confirmed by the WHO. A 65-year-old man infected with H7N9 also died in Hong Kong, the government said on Monday. The WHO reiterated there is no evidence as yet of any easy or sustained person-to-person transmission of the strain, and that the source of the human infections is still under investigation. Researchers in the United States said last month that while it is not impossible that H7N9 could become easily transmissible between people, it would need to undergo multiple mutations to do that. Scientists around the world are keeping a watchful eye, on alert for any sign the virus might develop that potential and start to spread rapidly. Claim: Death toll from new China bird flu rises: WHO.

A: Six more people in China have been confirmed as infected with the new H7N9 strain of bird flu and one of them has died, the World Health Organisation (WHO) said on Monday.
****
Q: Paragraph: The 2002-2003 SARS epidemic started in southern China and killed more than 700 people in mainland China, Hong Kong and elsewhere. Fears of a SARS recurrence arose this month after a slate of patients were hospitalized with an unexplained viral pneumonia in Wuhan, the capital of Hubei province. As of Sunday, 59 people were diagnosed with the condition and have been isolated while they receive treatment, according to the Wuhan Municipal Health Commission. Seven were in critical condition, while the rest were stable. The commission said in a statement that initial investigations have ruled out SARS — severe acute respiratory syndrome — as well as Middle East respiratory syndrome, influenza, bird flu and adenovirus. The commission previously said the condition’s most common symptom was fever, with shortness of breath and lung infections appearing in a “small number” of cases. There were no clear indications of human-to-human transmission. Several patients were working at the South China Seafood City food market in sprawling Wuhan’s suburbs. The commission said the market would be suspended and investigated. Hong Kong’s Hospital Authority said Sunday that a total of 15 patients in Hong Kong were being treated for symptoms including fever and respiratory infection after recent visits to Wuhan. Hospitals and doctors have been directed to report cases of fever in anyone who has traveled to Wuhan in the past 14 days, Hong Kong’s health chief, Sophia Chan, said Sunday. The hospital authority said it has activated a “serious response” level to curb spread of the infection. Chan warned Hong Kong residents against visiting wet markets and eating wild game in mainland China. The World Health Organization said it was closely monitoring the situation and maintaining contact with Chinese authorities. No travel or trade restrictions are necessary at this time, the WHO said. Claim: Local authorities: Mysterious illness in China is not SARS.

A:
The mysterious respiratory illness that has infected dozens of people in a central Chinese city is not SARS, local authorities said Sunday.
****